Rodgers Brothers Inc. Pacira Bio Sciences, Inc. Transaction History

Rodgers Brothers Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $536,590 - $650,475	-10,325 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $6,160 - $10,494	200 Added 1.98%	10,325 $542,000
Q1 2020 May 14, 2020	SELL	$28.4 - $50.7 $2,840 - $5,070	-100 Reduced 0.98%	10,125 $339,000
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $364,623 - $460,022	10,225 New	10,225 $389,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

Stay updated on Rodgers Brothers Inc. with notifications on news.